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Abstract A recent report suggested that platelet-derived growth
factor (PDGF) activates nuclear factor-UB (NF-UB) by phos-
phorylation of the protein kinase Akt [Romashkova and
Makarov, Nature 401 (1999) 86^90]. The present study
investigates the role of Akt in the activation of NF-UB by tumor
necrosis factor-K (TNFK, 10 ng/ml) and PDGF-BB (20 ng/ml) in
human vascular smooth muscle cells (SMC), skin and foreskin
fibroblasts. TNFK stimulated serine phosphorylation and degra-
dation of the inhibitory protein IUBK and strongly induced
nuclear NF-UB translocation and binding activity. PDGF did not
induce serine phosphorylation or degradation of IUBK and did
not enhance binding activity of NF-UB. In contrast, stimulation
with PDGF resulted in a marked phosphorylation of Akt, but no
Akt phosphorylation occurred after stimulation with TNFK.
These data suggest that Akt phosphorylation is not involved in
NF-UB activation in human SMC and fibroblasts. ß 2000 Fed-
eration of European Biochemical Societies. Published by Else-
vier Science B.V. All rights reserved.
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1. Introduction
Nuclear factor-UB (NF-UB) is an important modulator of
gene expression in immunity, in£ammation [1], apoptosis [2],
and atherosclerosis [3,4]. Accordingly, NF-UB is activated by
multiple stimuli, including ultraviolet radiation, T-cell activa-
tion, viruses, bacterial lipopolysaccharide, oxidants and cyto-
kines, such as tumor necrosis factor-K (TNFK) [1,5,6]. The
e¡ects of growth factors, such as platelet-derived growth fac-
tor (PDGF), on NF-UB activation are still not fully charac-
terized. It has been reported that PDGF induces NF-UB acti-
vation in embryonic kidney and carcinoma cells [7], in
¢broblasts [8,9], and in Jurkat T-cells [10]. The NF-UB signal-
ing pathway in vascular smooth muscle cells (SMC) has been
studied by Bourcier et al. [4]. In their investigation, stimula-
tion of NF-UB binding by PDGF or serum was much weaker
than stimulation by cytokines, such as interleukin-1L or
TNFK, while Bond et al. [11] found no NF-UB activation at
all by PDGF in SMC. In another recent study, stimulation of
¢broblasts with PDGF did not cause NF-UB activation, while
TNFK did [12]. The classical way of stimulating NF-UB is the
activation of IUB kinase (IKK) [13], subsequent phosphoryla-
tion [5,14], ubiquitination and degradation of IUBK [13]. NF-
UB then translocates to the nucleus and activates gene tran-
scription.
In two recent studies, a new pathway for the activation of
NF-UB by PDGF and TNFK has been described. Romash-
kova and Makarov [9] reported that PDGF stimulates the
protein kinase Akt by activation of Ras and phosphatidylino-
sitol 3-kinase (PI(3)K). Akt consecutively activates the IKK.
This results in IUB phosphorylation and activation of NF-UB.
Ozes et al. [7] have shown that TNF activates PI(3)K and its
downstream target Akt and this is followed by induction of
NF-UB binding activity.
In the present study, we investigated the involvement of
Akt in TNFK- and PDGF-BB-induced NF-UB activation in
three human cell types: vascular SMC, skin ¢broblasts and
foreskin ¢broblasts. We found no activation of NF-UB by
PDGF-BB, but a strong activation by TNFK. In contrast, a
marked phosphorylation of Akt occurred after stimulation
with PDGF-BB, but not after stimulation with TNFK.
Thus, evidence is presented that Akt phosphorylation is not
involved in the activation of NF-UB in cultured human vas-
cular SMC and ¢broblasts.
2. Materials and methods
2.1. Cell culture
Three types of human cells were used: SMC, skin ¢broblasts and
foreskin ¢broblasts. SMC were isolated from human saphenous veins
by the explant technique as previously described [15], skin ¢broblasts
were kindly provided by Dr. P. Ro«sen (Diabetes-Forschungsinstitut,
Heinrich-Heine-Universita«t Du«sseldorf, Germany), and foreskin ¢bro-
blasts were from the American Type Culture Collection (Manassas,
VA, USA). Cells were cultured in Dulbecco’s modi¢ed Eagle’s me-
dium containing 1 mM pyruvate, 2 mM L-glutamine, 1% (v/v) non-
essential fatty acids, 50 U/ml penicillin, 50 Wg/ml streptomycin and
15% fetal calf serum. Fibroblast medium contained 10% fetal calf
serum, but no pyruvate, glutamine or fatty acids. Cells were kept in
a humidi¢ed atmosphere of 5% CO2 and 95% air at 37‡C. Media were
changed twice a week and the cells passaged using trypsin (0.05%)/
ethylenediamine-tetraacetic acid (EDTA) (0.5 mM). Prior to stimula-
tion with TNFK (10 ng/ml) and PDGF-BB (20 ng/ml), cells were
serum-deprived for 72 h. Cell culture materials were purchased from
Becton Dickinson (Heidelberg, Germany), fetal calf serum was from
Life Technologies (Karlsruhe, Germany). SMC up to passage 12 and
¢broblasts of passages 13^20 were used for the study.
2.2. Western immunoblot analysis
Cell extracts were prepared in sodium dodecyl sulfate (SDS) lysis
0014-5793 / 00 / $20.00 ß 2000 Federation of European Biochemical Societies. Published by Elsevier Science B.V. All rights reserved.
PII: S 0 0 1 4 - 5 7 9 3 ( 0 0 ) 0 1 9 5 7 - 8
*Corresponding author. Fax: (49)-211-81 14781.
E-mail: kschroer@uni-duesseldorf.de
Abbreviations: EDTA, ethylenediamine-tetraacetic acid; IUB, inhibi-
tory protein UB; NF-UB, nuclear factor UB; PBS, phosphate-bu¡ered
saline; PDGF, platelet-derived growth factor; SDS, sodium dodecyl
sulfate; SMC, smooth muscle cells ; TNFK, tumor necrosis factor-K
FEBS 24070 1-9-00
FEBS 24070 FEBS Letters 481 (2000) 3^7
bu¡er (4% w/v SDS, 20% glycerol, 0.0625 M sodium dihydrogen
phosphate/disodium hydrogen phosphate, pH 7.0, 100 mM dithio-
threitol, 0.1% bromophenol blue). Proteins were separated by SDS
polyacrylamide gel electrophoresis (12%) and blotted onto polyvinyl-
idene di£uoride membranes (Immobilon1-P, Millipore, Bedford, MA,
USA). Membranes were blocked in Blotto (Tris-bu¡ered saline, 0.1%
Tween0-20, 5% w/v non-fat dry milk) and then probed with primary
antibodies (1:1000 in Blotto), followed by incubation with peroxidase-
conjugated secondary antibodies (1:3000 in Blotto). Bands were visu-
alized by enhanced chemiluminescence (Amersham Pharmacia Bio-
tech, Freiburg, Germany).
2.3. Immunoprecipitation
For immunoprecipitation, cells were washed with phosphate-bu¡-
ered saline (PBS) and lysed for 30 min on ice with 1 ml RIPA bu¡er
(50 mM Tris^HCl, pH 8.0, 150 mM NaCl, 1 mM EDTA, 0.4% de-
oxycholate, 1% Nonidet P-40) supplemented with protease inhibitors
(mammalian protease inhibitor cocktail, Sigma, Deisenhofen, Ger-
many; 1% phenylmethylsulfonyl £uoride of a saturated solution in
ethanol). After a brief sonication, samples were centrifuged at
12 000Ug for 10 min at 4‡C. Supernatants were pre-cleared with
10 Wl of a 50/50 (v/v) slurry of protein A^Sepharose (Amersham
Pharmacia Biotech, Freiburg, Germany) in PBS for 2 h at 4‡C. Pro-
tein A^Sepharose was pelleted by centrifugation at 12 000Ug for 1 min
and the supernatants were incubated with anti-IUBK antibodies (1 Wg)
on a rocking device overnight at 4‡C. Then, 10 Wl of a 50/50 (v/v)
slurry of protein A^Sepharose in PBS was added and incubated on a
rocking device for 1 h at 4‡C. The protein A^Sepharose was pelleted
and washed three times with RIPA bu¡er. Subsequently, proteins
were lysed in SDS lysis bu¡er and subjected to immunoblot analysis
as described above.
2.4. Electrophoretic mobility shift assay (EMSA)
Total cell extracts from TNFK- and PDGF-stimulated SMC were
prepared as described by Mu«ller et al. [16]. Nuclear extracts were
prepared according to Dignam et al. [17] with minor modi¢cations
as previously described in detail [18]. A non-radioactive labeling tech-
nique with digoxigenin-11-ddUTP (Roche Diagnostics, Basel, Switzer-
land) was used. The sequence of the NF-UB binding speci¢c oligonu-
cleotide was 5P-AGT TGA GGG GAC TTT CCC AGG C-3P. For
binding reaction, 6 Wg protein was incubated with 0.155 pmol of
3Pend-labeled probe and 3 Wg poly(dI-dC) in binding bu¡er (Roche
Diagnostics, Basel, Switzerland) in a ¢nal volume of 20 Wl for 15 min
at room temperature. A 25-fold excess of non-labeled probe was
added to the reaction mixture for competition experiments. For super-
shift assays, antibodies (1 Wg) were added to proteins 45 min before
using the labeled probe. Electrophoresis was carried out on a 6%
polyacrylamide gel at 4‡C. Samples were transferred to positively
charged nylon membranes (Roche Diagnostics, Basel, Switzerland),
blocked in blocking bu¡er (1% blocking reagent, 0.1 M maleic acid,
0.15 M NaCl, pH 7.5) and then incubated with anti-digoxigenin-Fab
fragments (1:10 000 in blocking bu¡er) conjugated with alkaline phos-
phatase. Finally, bands were visualized by chemiluminescence using
the CSPD0 system (Roche Diagnostics, Basel, Switzerland).
2.5. Immuno£uorescence microscopy
For immuno£uorescence microscopy, cells were washed with PBS,
¢xed for 5 min with cold (320‡C) methanol and air-dried. Then, cells
were washed three times with PBS, blocked for 20 min with 10% horse
serum (Vector Laboratories, Burlingame, CA, USA) in PBS, and in-
cubated with anti-NF-UB (p65) antibodies (2 Wg/ml in 1.5% horse
serum in PBS) for 1 h. After washing with PBS, rhodamine-conju-
gated secondary antibodies (1:100 in 1.5% horse serum in PBS) were
incubated for 45 min. Coverslips were mounted in SlowFade1 anti-
fade reagent (Molecular Probes, Eugene, OR, USA) and samples were
analyzed using a £uorescence microscope (IX-50, Olympus Optical,
Hamburg, Germany).
2.6. Antibodies
Rabbit a⁄nity-puri¢ed polyclonal antibodies against IUBK, IUBL,
NF-UB p50 and NF-UB p65 were obtained from Santa Cruz Biotech-
nology (Heidelberg, Germany). Phospho-speci¢c (Ser32) IUBK and
(Thr308) Akt antibodies were from New England Biolabs (Schwal-
bach, Germany). Peroxidase-conjugated anti-rabbit antibodies were
from Dianova (Hamburg, Germany). Rhodamine-conjugated anti-
rabbit antibodies were from Roche Diagnostics (Basel, Switzer-
land).
3. Results
3.1. TNFK but not PDGF stimulates IUBK phosphorylation and
degradation
The e¡ects of PDGF (20 ng/ml) on IUBK in cultured human
vascular SMC, skin and foreskin ¢broblasts were compared to
the e¡ects of TNFK (10 ng/ml). Using phospho-speci¢c (Ser32)
antibodies, a time-dependent phosphorylation of IUBK by
TNFK was observed. IUBK phosphorylation was already de-
tected 5 min after stimulation with TNFK, maximal e¡ects
were seen after 10 min, and phosphorylated bands disap-
peared after 30 min (Fig. 1A). Degradation of IUBK was de-
tected 10 min after stimulation and reached its maximum at
15 min. Within 60^90 min, IUBK reached control levels (Fig.
1B). In contrast, PDGF (20 ng/ml) did not stimulate either
Fig. 1. Western blots demonstrating the e¡ects of TNFK and PDGF on IUBK and IUBL in SMC. Cells were serum-starved for 72 h and stimu-
lated with TNFK (10 ng/ml) or PDGF (20 ng/ml) for the times indicated. Cell extracts were analyzed by Western blot. In contrast to PDGF,
TNFK time-dependently stimulated serine phosphorylation (A) and degradation (B) of IUBK. Similar results were obtained in three to four in-
dependent experiments, using SMC and ¢broblasts.
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phosphorylation (Fig. 1A) or degradation of IUBK (Fig. 1B).
Even after longer stimulation periods (up to 5 h), PDGF did
not induce IUBK degradation (not shown). IUBL, which is also
expressed in SMC and ¢broblasts [4], was not a¡ected by
either TNFK or PDGF (not shown).
Consistent with these ¢ndings, we were able to immunopre-
cipitate IUBK from SMC stimulated with PDGF for di¡erent
time periods (Fig. 2). In cells stimulated with TNFK for 5^10
min, a double band was immunoprecipitated with anti-IUBK
antibodies (Fig. 2), indicating IUBK phosphorylation. After
20 min of stimulation with TNFK, no IUBK could be immu-
noprecipitated, indicating IUBK degradation. IUBK returned to
immunoprecipitable levels at 60 min.
3.2. PDGF does not activate NF-UB
NF-UB binding activity was studied by EMSA. In all three
cell lines, TNFK induced maximum NF-UB binding activity
after 15^30 min (Fig. 3). In contrast, PDGF did not induce
NF-UB binding activity within 75 min of stimulation (Fig. 3).
Even longer stimulation with PDGF (up to 120 min) did not
induce NF-UB binding activity (not shown).
In order to quantify the di¡erent potencies of TNFK and
PDGF, nuclear translocation of NF-UB (p65) was studied at
the single cell level by immuno£uorescence microscopy. In
unstimulated controls, nuclear localization of NF-UB (p65
subunit) was observed in 1 þ 1% of SMC (means þ S.E.M.,
n = 3). Stimulation of SMC with TNFK for 20 min resulted
in a marked nuclear translocation of NF-UB (p65) in 97 þ 3%
of TNFK-stimulated cells (means þ S.E.M., n = 3) (Fig. 4). In
contrast, no signi¢cant nuclear NF-UB translocation was seen
when cells were stimulated with PDGF for 30 min (3 þ 1% of
SMC, means þ S.E.M., n = 3) (Fig. 4). Similar results were
found in ¢broblasts. Even after longer stimulation (up to
4 h), PDGF-induced nuclear NF-UB translocation was not
increased (not shown).
3.3. PDGF but not TNFK stimulates Akt phosphorylation
In order to assess whether Akt phosphorylation is involved
in the activation of NF-UB, Western blot analyses were per-
formed with phospho-speci¢c (Thr308) anti-Akt antibodies.
After stimulation of cells with PDGF, Akt phosphorylation
was strongly induced after 5 min, was maximal after 10 min
and declined within 90 min (Fig. 5). In contrast, stimulation
with TNFK did not result in phosphorylation of Akt (Fig. 5).
4. Discussion
NF-UB is involved in the expression of numerous cytokines,
adhesion molecules, regulation of apoptosis, and is also be-
lieved to be involved in cell proliferation [7,15,19]. In addi-
tion, this transcription factor is regarded to be a key regulator
of in£ammatory responses [20]. Recently, the activation of
NF-UB by Akt has been described [7,9]. The activity of the
serine/threonine kinase Akt has been shown to be stimulated
by growth factors acting through receptor tyrosine kinases
such as PDGF, epidermal growth factor, and insulin [21,22].
Physiologically, Akt signaling seems to be involved in cell
survival and suppression of apoptosis [23,24]. Among the nu-
Fig. 2. Immunoprecipitations demonstrating the e¡ects of TNFK
and PDGF on IUBK in SMC. SMC were serum-starved for 72 h
and stimulated with TNFK (10 ng/ml) or PDGF (20 ng/ml) for the
times indicated. IUBK was immunoprecipitated from total cell ex-
tracts and immunoprecipitates were analyzed by Western blot using
IUBK antibodies. After stimulation with TNFK a transient double
band occurred, indicating IUBK phosphorylation. After 20 min stim-
ulation with TNFK, IUBK could not be immunoprecipitated suggest-
ing its degradation. In contrast, in PDGF-treated cells, IUBK was
immunoprecipitated throughout the stimulation period. Similar re-
sults were obtained in three independent experiments.
Fig. 3. EMSA demonstrating the induction of NF-UB binding activity by TNFK and PDGF in SMC. SMC were serum-starved for 72 h and
stimulated with TNFK (10 ng/ml) or PDGF (20 ng/ml) for the times indicated. Total cell extracts were subjected to EMSA. Speci¢city of the
retarded bands was determined using anti-p65 antibodies (p65) and anti-p50 antibodies (p50), as well as by competition with 25Uexcess of un-
labelled probe (comp.) (samples from cells stimulated with TNFK for 15 min were used for speci¢city experiments). A marked, time-dependent
induction of NF-UB binding activity was seen with TNFK. NF-UB binding activity with PDGF was not signi¢cantly induced. Similar results
were obtained in three independent experiments.
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merous growth factors mediating migration and proliferation
of SMC and ¢broblasts, PDGF plays a central role [25]. For
example, selective inhibition of the PDGFL receptor with neu-
tralizing antibodies signi¢cantly reduced neointima formation
in baboons [26].
Because of the recently described new pathway of NF-UB
activation by PDGF [9] and the involvement of Akt phos-
phorylation in NF-UB activation [7], we focused this study
on the role of Akt in PDGF- and TNFK-induced NF-UB
activation using cultured human vascular SMC and ¢bro-
blasts. As compared to TNFK, PDGF did not stimulate
NF-UB in any of these cells. No signi¢cant nuclear transloca-
tion of NF-UB (p65) was observed after PDGF treatment.
Consistent with these ¢ndings, NF-UB binding activity, mea-
sured by EMSA, was strongly induced by TNFK and not by
PDGF. Although a strong activation of NF-UB occurred after
stimulation with TNFK, no Akt phosphorylation was de-
tected. Vice versa, PDGF, which did not activate NF-UB,
caused a marked phosphorylation of Akt.
In a recent study with human skin ¢broblasts and rat ¢bro-
blast-like synoviocytes, PDGF-induced NF-UB activation co-
incided with phosphorylation and degradation of IUBK. It was
also shown that Akt is principally able to activate NF-UB [9].
Another study demonstrated that Akt phosphorylation is in-
ducible by TNFK and coincides with NF-UB activation [7].
Thus, PDGF- and TNFK-induced activation of NF-UB is, at
least in some cell systems, linked to the IUB kinase pathway.
Our ¢ndings appear to be at variance with the observation
that Akt is necessary for NF-UB activation. A possible explan-
ation could be that some of the studies reporting involvement
of Akt in the NF-UB activation pathway were performed in
cells with a high potential for proliferation, such as embryonic
kidney cells, carcinoma cells [7], or T-cells [10]. Interestingly,
in the study describing PDGF-induced activation of NF-UB
by Akt, no Akt phosphorylation was found by TNFK [9],
indicating that Akt is not essential for NF-UB activation.
Thus, it is possible that Akt is principally linked to the NF-
UB pathway, especially in embryonic or dedi¡erentiated cells.
It might be speculated that a link between Akt, which pro-
vides a survival signal protecting cells from apoptosis [24], and
the NF-UB pathway might contribute to the proliferation po-
tency of some cell types. This hypothesis is supported by the
observation that Akt is enhanced in many human tumors [24].
In other cell systems with a lower potential for cell division,
this pathway might be deactivated or have lost its e⁄cacy.
Because the e¡ects of Akt in the signaling cascade can vary
widely in di¡erent cell types, it has been suggested that cul-
tured cells can develop individual molecular mechanisms in
cellular signaling [23].
Taken together, our ¢ndings demonstrate that stimulation
Fig. 4. Immuno£uorescence staining demonstrating nuclear translocation of NF-UB (p65) in SMC. Cells were serum-starved for 72 h and stimu-
lated with TNFK (10 ng/ml, 20 min) or PDGF (20 ng/ml, 30 min). The localization of p65 was determined by immuno£uorescence microscopy.
In unstimulated cells, p65 was localized in the cytoplasm. After stimulation with TNFK, p65 was translocated into the nuclei in almost 100%
of the cells. Stimulation with PDGF resulted in a much weaker response. Similar results were obtained in three independent experiments, using
SMC and ¢broblasts. Arrows indicate NF-UB translocation in control cells and in PDGF-stimulated cells.
Fig. 5. Western blot demonstrating the e¡ects of PDGF on Akt phosphorylation in SMC. Cells were serum-starved for 72 h and stimulated
with TNFK (10 ng/ml) or PDGF (20 ng/ml) for the times indicated. Cell extracts were analyzed by Western immunoblotting. In contrast to
TNFK, PDGF time-dependently stimulated Akt phosphorylation. Similar results were obtained in three independent experiments.
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with PDGF induces Akt phosphorylation in cultured human
vascular SMC, skin and foreskin ¢broblasts, but does not
result in NF-UB activation. In contrast, TNFK strongly acti-
vated NF-UB, but was not su⁄cient to stimulate Akt phos-
phorylation in all cell types used. It is concluded that Akt
phosphorylation is not required for NF-UB activation in these
cells.
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